Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents.

Bunyasi EW, Geldenhuys H, Mulenga H, Shenje J, Luabeya AKK, Tameris M, Nemes E, Mahomed H, Rozot V, Wood R, Scriba T, Andrews JR, Hatherill M.

Int J Tuberc Lung Dis. 2019 May 1;23(5):571-578. doi: 10.5588/ijtld.18.0283.

PMID:
31097065
2.

Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.

Usemann J, Ledergerber M, Fink G, Ritz N.

Int J Tuberc Lung Dis. 2019 May 1;23(5):579-586. doi: 10.5588/ijtld.18.0356.

PMID:
31097066
3.

Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.

Lee S, Lee JE, Kang JS, Lee SO, Lee SH.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):422-427. doi: 10.5588/ijtld.18.0198.

PMID:
31064620
4.

QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA.

Epstein RL, Bhagavathula M, Saag LA, Verma S, Kan CK, Mesick J, Kamineni P, White LF, Barnett ED, Salgame P, Hochberg NS.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):482-490. doi: 10.5588/ijtld.18.0540.

5.

Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.

Berrocal-Almanza LC, Botticello J, Piotrowski H, Karnani N, Kon OM, Lalvani A, Zenner D.

Int J Tuberc Lung Dis. 2019 May 1;23(5):563-570. doi: 10.5588/ijtld.18.0230.

6.

Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality.

Golub JE, Mok Y, Hong S, Jung KJ, Jee SH, Samet JM.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):507-513. doi: 10.5588/ijtld.18.0103.

PMID:
31064631
7.

Magnitude of Mycobacterium tuberculosis transmission among household and non-household contacts of TB patients.

Kato-Maeda M, Choi JC, Jarlsberg LG, Grinsdale JA, Higashi J, Kawamura LM, Osmond DH, Hopewell PC.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):433-440. doi: 10.5588/ijtld.18.0273.

PMID:
31064622
8.

Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study.

Whitehouse ER, Perrin N, Levitt N, Hill M, Farley JE.

Int J Tuberc Lung Dis. 2019 May 1;23(5):587-593. doi: 10.5588/ijtld.18.0374.

PMID:
31097067
9.

Short-course treatment outcomes and adverse events in adults and children-adolescents with MDR-TB in Niger.

Harouna SH, Ortuno-Gutierrez N, Souleymane MB, Kizito W, Morou S, Boukary I, Zolfo M, Benedetti G, Piubello A.

Int J Tuberc Lung Dis. 2019 May 1;23(5):625-630. doi: 10.5588/ijtld.17.0871.

PMID:
31097073
10.

Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study.

Cho PJ, Wu CY, Johnston J, Wu MY, Shu CC, Lin HH.

Int J Tuberc Lung Dis. 2019 May 1;23(5):555-562. doi: 10.5588/ijtld.18.0225.

PMID:
31097063
11.

Detection of airborne Mycobacterium tuberculosis complex in high-risk areas of health care facilities in Thailand.

Sornboot J, Aekplakorn W, Ramasoota P, Bualert S, Tumwasorn S, Jiamjarasrangsi W.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):465-473. doi: 10.5588/ijtld.18.0218.

PMID:
31064626
12.

Fully vs. partially integrated services for TB-HIV in Myanmar: a health services review and a cohort study.

Kyi MS, Aung ST, Oo HN, Chongsuvivatwong V.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):498-506. doi: 10.5588/ijtld.18.0397.

PMID:
31064630
13.

Tuberculosis infection prevention and control measures in DOTS centres in Lagos State, Nigeria.

Kuyinu YA, Goodman OO, Odugbemi BA, Adeyeye OO, Mohammed AS, Odusanya OO.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):474-481. doi: 10.5588/ijtld.18.0348.

PMID:
31064627
14.

Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.

Heldal E, Dlodlo RA, Mlilo N, Nyathi BB, Zishiri C, Ncube RT, Siziba N, Sandy C.

Int J Tuberc Lung Dis. 2019 May 1;23(5):612-618. doi: 10.5588/ijtld.18.0549.

PMID:
31097071
15.

Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis.

Hofmann-Thiel S, Molodtsov N, Duffner C, Kadyrov A, Kalmambetova G, Kabirov O, Rajabov A, Parpieva N, Sayfutdinov Z, Vogel M, Vogel H, Antonenka U, Hoffmann H.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):458-464. doi: 10.5588/ijtld.18.0615.

PMID:
31064625
16.

Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda.

Musaazi J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, Reynolds SJ, Manabe YC, Castelnuovo B.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):514-521. doi: 10.5588/ijtld.18.0306.

PMID:
31064632
17.

Integrating tuberculosis and mental health services: global receptivity of national tuberculosis program directors.

Sweetland AC, Galea J, Shin SS, Driver C, Dlodlo RA, Karpati A, Wainberg ML.

Int J Tuberc Lung Dis. 2019 May 1;23(5):600-605. doi: 10.5588/ijtld.18.0530.

18.

Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study.

Ncayiyana JR, Bassett J, West N, Westreich D, Musenge E, Emch M, Pettifor A, Hanrahan CF, Schwartz SR, Sanne I, van Rie A.

BMC Infect Dis. 2016 Nov 8;16(1):661.

19.

Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.

Kibuule D, Rennie TW, Ruswa N, Mavhunga F, Thomas A, Amutenya R, Law MR, Günther G, Ette E, Godman B, Verbeeck RK.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):441-449. doi: 10.5588/ijtld.17.0785.

PMID:
31064623
20.

Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.

Gupte AN, Selvaraju S, Paradkar M, Danasekaran K, Shivakumar SVBY, Thiruvengadam K, Dolla C, Shivaramakrishnan G, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Subramanian B, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub JE, Bollinger R, Chandrasekaran P, Mave V, Gupta A.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):450-457. doi: 10.5588/ijtld.18.0551.

PMID:
31064624

Supplemental Content

Support Center